Description
| Product Name | CAT.No | Size |
| Thalassaemia (α & ß) Control Level 1 | BXC0665A | 2 x 0.5ml |
| Thalassaemia (α & ß) Control Level 2 | BXC0665B | 2 x 0.5ml |
Product Description
The Biorex Diagnostics Thalassaemia Control provides human serum–based, ready-to-use or lyophilised materials for accurate quality control of haemoglobin assays. This inherited blood disorder involves abnormal haemoglobin production, which can lead to anaemia of varying severity. Accurate laboratory assessment is essential for diagnosing α- and ß-thalassaemia, carrier screening, and prenatal testing. Reliable quality control materials help ensure assay precision, reproducibility, and performance consistency across clinical laboratories, supporting informed patient management and early intervention.
These controls are formulated from human serum to closely mimic patient samples, providing clinically relevant testing conditions. They include multiple haemoglobin variants, such as HbA2, HbF, and HbS, allowing comprehensive evaluation of abnormal haemoglobin patterns. The controls are available in flexible formats, either liquid-stable or lyophilised, offering long-term stability and convenient handling for diverse laboratory workflows.
Key Features
• Human serum–based materials: Replicates patient samples to provide meaningful and clinically relevant results.
• Multi-analyte coverage: Includes HbA2, HbF, and HbS for complete monitoring of haemoglobin variants.
• Precision and accuracy assessment: Ensures reproducibility and reliability across multiple runs and instruments.
• Flexible formats: Available as liquid-stable or lyophilised preparations for extended shelf life and convenient handling.
Benefits
Routine use of the Biorex Diagnostics Control enables laboratories to maintain high standards in haemoglobin testing, detect assay deviations early, and comply with ISO 15189, CAP, and CLIA standards. These materials support reliable quantification of key haemoglobin variants, facilitating accurate diagnosis, carrier identification, and prenatal screening. By providing precise and reproducible quality control, the kit enhances laboratory confidence, strengthens quality assurance programs, and contributes to improved patient outcomes. Suitable for clinical and research settings, this Control kit ensures consistent, dependable performance for haemoglobin assays, enabling laboratories to deliver accurate, high-quality results for effective management of inherited haemoglobin disorders across diverse patient populations.
Contact Us for more information.